USD 7.82 billion
Next Generation Sequencing Market Size, Share, Growth Analysis, By Product & Service(NGS Consumables, Sequencing Services (Exome & Targeted Resequencing and Custom Panels, RNA Sequencing, DE NOVO Sequencing), By Technology(Sequencing By Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-molecule Real-time Sequencing), By Application(Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications)), By End User(Academic Institutes And Research Centers, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Reference Laboratories), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35D2046 |
Region:
Global |
Published Date: August, 2024
Pages:
157
|Tables:
98
|Figures:
76
Next Generation Sequencing Market Insights
Next Generation Sequencing Market size was valued at USD 9.27 Billion in 2023 and is poised to grow from USD 10.98 Billion in 2024 to USD 42.71 Billion by 2032, growing at a CAGR of 18.5% during the forecast period (2025-2032).
Next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS is less dependent on fragment-cloning strategies that are used in Sanger genome sequencing. The advantages of NGS over Sanger’s sequencing method include low cost, high accuracy and speed, precise results even if small amounts of samples are used. Thus, NGS is widely used in biomarker discovery, cancer studies, personalized medicine, agriculture and animal studies, etc.
Genome sequencing has also been applied to understanding how Covid-19 spreads and can inform how interventions affect disease progression and subsequent treatments. The Covid-19 Genomics U.K. Consortium (COG-U.K.) was set up in March 2020, to utilize Whole-Genome Sequencing to investigate the coronavirus genome. Partners in the cooperation are the Welcome Sanger Institute, the NHS, Public Health Agencies, and other academic institutions. These organizations have collaborated on mapping the virus’s evolution and spread.
US Next Generation Sequencing Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Instruments
Fastest Growth
Instruments
Growth Rate
18.5% CAGR
Global Next Generation Sequencing Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Next Generation Sequencing Market Segmental Analysis
The Global Next Generation Sequencing Market is segmented into Product and Service, Technology, Application, End User and region. Based on the Product & Service, the market is segmented into NGS Consumables, Sequencing Services, Pre-sequencing Products & Services, NGS Platforms, and Bioinformatics. Based on the Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-molecule Real-time Sequencing, and Others. Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agricultural and Animal Research, and Other. Based on the End-user, the market is segmented into Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Reference Laboratories, and Others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.
Analysis by Application
Based on application, the drug discovery & development segment is dominating the market with the largest market share. This segment will continue to increase in future due to the rising prevalence of chronic diseases. Next generation sequencing techniques are extremely vital for drug development and discovery. This is because it has the potential to generate multiple layers of genomic data like genomic changes, transcriptome profiling and quantification, and epigenetic modifications. It can also generate genomic information that is necessary for the target disease. Furthermore, with the help of NGS a new age genetic-based medicine development has also started owing to the high-level research on genotype-phenotype interactions on human population. The NGS is rapidly becoming a capable and promising tool for diagnosing diseases, especially pathogen-detection process for infectious disease diagnosis.
The agriculture and animal research segment are witnessing the fastest growth. This is mainly because next generation sequencing can strengthen comprehensive genomic analysis. This allows innovations for crop enhancement, livestock breeding, and diseases resistance research. The segment is also augmenting exponentially due to the growing applications of NGS. These solutions are used for improving agricultural productivity, ensuring food security, and addressing difficulties in animal health, boosting the rapid expansion of the segment.
Analysis by End Use
Based on end use, the academic institutions & research centers are dominating the market with maximum share. The academic institutions and research centers are the initial adopters of next generation sequencing technologies, boosting the market growth. This is also increasing the speed of technological breakthroughs. NGS has become a vital part in a vast range of academic research developments due to its importance in developing genomics, molecular biology, and biomedical sciences. Furthermore, many government facilities are also financing research for accelerating the implementation of NGS in academic settings. Government funding is making it easy to buy NGS equipment and promotes research using genomic technologies.
The hospitals and clinic segment are the fastest growing in the next generation sequencing market. These hospitals and clinics are making progress in drug development due to genomics. This has resulted in the recognition of safer and more effective medications. Furthermore, the reliance on hospitals and clinics has also increased owing to the detection of different diseases like cancers, infectious diseases, and pathological conditions. It has become easy to detect these diseases with the help of next generation gene sequencing. It is an efficient tool for neonatal and genetic screening. Detecting a disease's genomic and genetic components can help in developing a diagnostic strategy. This information can assist with patient care and counseling.
To get detailed analysis on other segments, Request For Free Sample Report
Next Generation Sequencing Market Regional Insights
Based on regions, North America is dominating the next generation sequencing market with the largest share. This is mainly because the region has some of the best clinical labs that use NGS for offering genetic testing services. Furthermore, increasing investment in R&D, the availability of advanced medical research structure, and the advancement of WGS is also positively influencing the market growth in this region. The presence of prominent manufacturers, active government support, and the increasing prevalence of cancer are also driving the expansion of the market in North America. The region also has many prestigious research institutions, top universities, and major pharmaceutical companies, equipped with financial resources for investing in the most advanced NGS technologies. Such infrastructure not only supports outstanding research in many scientific groups but also boosts innovation in genomic medicine and biotechnology.
Asia-Pacific is the fastest growing region in the next generation sequencing market. This is mainly due to the increasing prevalence of diseases like cancer and the extending government involvement. These factors are massively contributing to the development of the next generation sequencing market in this region. Another major factor boosting the expansion of the market in this region is the increasing focus of prominent market players on offering advanced and efficient NGS technologies to the emerging economies. This has helped in meeting the demand for genomic therapeutics and whole-genome sequencing for personalized medicine. Growing funding, increasing government support, and strategic initiatives taken by market leaders are also strengthening the region’s market for next-generation sequencing.
Global Next Generation Sequencing Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Next Generation Sequencing Market Dynamics
Drivers
High Demand for Personalized Medicine
- NGS allows extensive analysis of a person’s genome, which helps in the identification of genetic variations. This influence drug response, susceptibility to diseases, and possible adverse reactions. This personalized technique is boosting the incorporation of NGS into clinical settings, where it improves treatment efficiency by customizing therapies that match the genetic profiles of patients.
Growing Popularity of Precision Oncology
- In oncology, NGS plays a vital part in recognizing particular mutations within tumors. This molecular profiling allows oncologists to prescribe targeted therapies developed for addressing the unique genetic features of every patient’s cancer. Therefore, NGS contributes massively to enhancing treatment results and patient survival rates in cancer care.
Restraints
High Expense of NGS Processes
- The expense related with NGS processes, encompassing sequencing, data analysis, and interpretation, creates a huge barrier to accessibility for both patients and medical professionals. The cost related to acquiring and maintaining NGS technologies restricts its utilization in clinical settings, particularly in resource-constrained structures.
Data Storage and Analysis
- NGS creates massive amounts of genomic data, developing huge difficulties for storage, management, analysis, and interpretation. Effective data management solutions that are scalable, secure, and cost-efficient are vital for managing such huge datasets generated by NGS platforms. Developments in bioinformatics tools and cloud computing technologies are vital in facilitating robust data analysis pipelines. This is also allowing researchers and clinicians to extract valuable insights from genomic information.
Request Free Customization of this report to help us to meet your business objectives.
Next Generation Sequencing Market Competitive Landscape
The next-generation sequencing market can be defined by intense competition among the prominent market players. The introduction of unique platforms that are fast, small, and affordable is one of the tactics utilized by the organizations to enhance their market position. Cerba Research, declared two new COVID-19 exploratory tools in January 2021, one PCR-based and the NGS-based for improving research and development necessary for vaccine development against coronavirus.
Top Player’s Company Profile
- Illumina Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- PerkinElmer Inc. (US)
- BGI Group (China)
- Agilent Technologies Inc. (US)
- Eurofins Scientific SE (Luxembourg)
- Pacific Biosciences of California Inc. (US)
- Oxford Nanopore Technologies (UK)
- QIAGEN NV (Netherlands)
- F. Hoffmann-La Roche AG (Switzerland)
- GENEWIZ Inc. (US)
- Psomagen, Inc. (South Korea)
- 10x Genomics Inc. (US)
Recent Developments
- In April 2024, Merck KGaA unvelied the first all-in-one, validated genetic stability assay. The Aptegra CHO genetic stability assay utilizes whole genome sequencing and bioinformatics accelerating biosafety testing for clients,
- In January 2024, QIAGEN has upgraded its QIAGEN CLC Genomics Workbench Premium with the assistance of LightSpeed technology. It can now include support for next-generation sequencing (NGS) in somatic cancer secondary analysis.
- In January 2024, Beckman Coulter, Inc. and Polycarbin collaborates. The goal of this partnership is to revolutionize lab sustainability for liquid handling automation plastics.
Next Generation Sequencing Key Market Trends
Rare Disease Diagnosis
- NGS provides a powerful tool for diagnosing rare genetic disorders accurately and swiftly. By sequencing an individual’s genome, clinicians can pinpoint the genetic basis of rare diseases, enabling early intervention and more effective management strategies. This capability drives market growth as healthcare providers increasingly rely on NGS for precise and timely diagnosis of challenging medical conditions.
Increasing Genomics Research Funding
- Increased investment from governments and private sectors in genomics research supports the development of innovative NGS applications. This funding drives exploration into new areas of genomics, fosters collaborations between academia and industry, and stimulates breakthroughs in understanding genetic mechanisms underlying diseases. Consequently, ongoing research initiatives contribute to the continuous evolution and broader acceptance of NGS technologies worldwide.
Next Generation Sequencing Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global next generation sequencing market is experiencing a high adoption rate. This is mainly due to growing applications and interventions like diagnostics, biomarker discovery, and personalized medicine. NGS is better and more advanced technology for identifying genes because of the accessibility of sequence-based genomic analysis. This is mainly due to the surge in genome mapping projects. This is mainly due to the surge in genome mapping projects. These factors are propelling the growth of the NGS market.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 9.27 Billion |
| Market size value in 2032 | USD 42.71 Billion |
| Growth Rate | 18.5% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Next Generation Sequencing Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Next Generation Sequencing Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Next Generation Sequencing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Next Generation Sequencing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Next Generation Sequencing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Next Generation Sequencing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
